| |
| |
|
| Insider
Information: |
Peltz Stuart Walter |
| Relationship: |
Director |
| City: |
South Plainfield |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
189,223 |
|
|
Indirect Shares
|
54,903 |
|
|
| Direct
Value |
$5,784,563 |
|
|
|
Indirect Value
|
$1,868,349 |
|
|
| Total
Shares |
244,126 |
|
|
| Total
Value |
$7,652,912 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
23
|
|
Stock
price went up :
|
0
|
6
|
| Stock
price went down : |
0
|
17
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -511.4%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
PTC Therapeutics, Inc. |
PTCT |
|
2023-01-31 |
166,962 |
2023-01-31 |
54,903 |
Premium* |
|
|
Orchestra BioMed Holdings Inc. |
OBIO |
Director |
2020-08-03 |
22,261 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
77 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PTCT |
PTC Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2014-03-07 |
4 |
AS |
$28.82 |
$819,975 |
D/D |
(27,414) |
161,389 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2014-03-24 |
4 |
AS |
$27.39 |
$761,147 |
D/D |
(25,487) |
135,902 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2014-10-01 |
4 |
AS |
$42.09 |
$1,770,203 |
D/D |
(41,501) |
94,401 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2015-03-09 |
4 |
AS |
$70.67 |
$3,338,927 |
D/D |
(47,201) |
47,200 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2015-03-23 |
4 |
AS |
$68.96 |
$3,263,428 |
D/D |
(47,200) |
0 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2015-06-08 |
4 |
OE |
$10.85 |
$840,615 |
D/D |
77,476 |
77,476 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2015-06-08 |
4 |
AS |
$53.81 |
$4,047,174 |
D/D |
(73,700) |
3,776 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2015-06-09 |
4 |
AS |
$52.89 |
$1,401,617 |
D/D |
(26,300) |
3,776 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2015-06-09 |
4 |
OE |
$10.85 |
$285,355 |
D/D |
26,300 |
30,076 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2015-06-17 |
4 |
OE |
$10.85 |
$37,975 |
D/D |
3,500 |
7,276 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2017-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
21,600 |
28,876 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2018-01-05 |
4 |
S |
$18.03 |
$40,207 |
D/D |
(2,230) |
26,646 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2019-01-07 |
4 |
S |
$34.75 |
$61,299 |
D/D |
(1,764) |
24,882 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2019-01-07 |
4 |
S |
$34.75 |
$25,993 |
I/I |
(748) |
17,538 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2019-01-22 |
4 |
A |
$0.00 |
$0 |
I/I |
4,620 |
22,158 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2019-12-03 |
4 |
AS |
$50.00 |
$1,123,150 |
I/I |
(22,463) |
18,676 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2019-12-03 |
4 |
OE |
$10.85 |
$265,169 |
I/I |
18,981 |
26,332 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2020-01-06 |
4 |
S |
$48.17 |
$86,558 |
D/D |
(1,797) |
23,085 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2020-01-06 |
4 |
S |
$48.17 |
$38,438 |
I/I |
(798) |
18,525 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2020-01-23 |
4 |
S |
$53.25 |
$22,523 |
I/I |
(423) |
18,102 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2020-01-29 |
4 |
A |
$0.00 |
$0 |
D/D |
33,000 |
56,085 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2020-01-29 |
4 |
A |
$0.00 |
$0 |
I/I |
4,855 |
22,957 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2020-05-05 |
4 |
AS |
$50.33 |
$5,533,592 |
D/D |
(109,928) |
56,085 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2020-05-05 |
4 |
OE |
$10.85 |
$1,192,719 |
D/D |
109,928 |
166,013 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2020-05-18 |
4 |
OE |
$10.85 |
$68,181 |
D/D |
6,284 |
62,369 |
0 |
- |
|
77 Records found
|
|
Page 1 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
